Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Abbie_Celniker
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
precision medicine
transcription factor drug discovery |
| gptkbp:foundedYear |
2020
|
| gptkbp:fundedBy |
$123 million
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flare Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Invus
gptkb:Omega_Funds gptkb:Perceptive_Advisors gptkb:Vida_Ventures gptkb:SR_One gptkb:Casdin_Capital gptkb:Third_Rock_Ventures gptkb:Atlas_Venture gptkb:Boxer_Capital gptkb:Novartis_Venture_Fund |
| gptkbp:notableEmployee |
gptkb:Alan_D._Frankel
gptkb:Abbie_Celniker gptkb:Catherine_Sabatos-Peyton gptkb:Robert_Sims |
| gptkbp:specializesIn |
oncology
small molecule therapeutics |
| gptkbp:website |
https://flaretx.com/
|
| gptkbp:bfsParent |
gptkb:Third_Rock_Ventures
|
| gptkbp:bfsLayer |
6
|